Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04515186Phase 3Completed
Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World
Cutaneous Leishmaniases
PrincipalinvestigatorStart date: 2021-01-26

Research Network

Collaboration Network

6 collaborators·15 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Fundación Nacional de Dermatología

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Marcos López, PhD

The University of Akron

Moderately Similar
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score30%

Patricio López-Jaramillo, MD, PhD

Cardiovascular Foundation of Colombia

Moderately Similar
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score30%

Edgar M Carvalho, MD, PhD

Federal University of Bahia

Moderately Similar
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score30%

Rick M Fairhurst, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Moderately Similar
8 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score30%

Charles Lacey, BMBS, MD

University of York

Moderately Similar
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score30%

Christian F Rueda-Clausen, MD

Fundación Cardiovascular de Colombia

Moderately Similar
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score30%

Harry S Nielsen, Ph.D.

Nielsen BioSciences, Inc.

Moderately Similar
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score30%

Wim Adriaensen, PhD

Institute of Tropical Medicine Antwerp

Moderately Similar
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score30%

Pierre Buffet, MD, PhD

Assistance Publique - Hôpitaux de Paris

Moderately Similar
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score30%

Ivan Dario Velez, Prof

PECET, Universidad de Antioquia, Medellin, Colombia

Moderately Similar
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04515186Phase 3PrincipalInvestigator

Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Cutaneous Leishmaniases
Completed

All 1 trials loaded